Current Research and Scholarly Interests
Dr. Victoria Cosgrove directs the Prevention and Intervention (PI) Laboratory, housed in the Division of Child and Adolescent Psychiatry, which investigates the etiology and treatment of affective psychopathology across the life span. Our mission is focused on two overarching aims: (1) to examine, using multilevel analysis (i.e., behavioral, genetic, immunological, etc.), stress-related etiological phenomena involved in the emergence of affective psychopathology in youth and adults within a diathesis-stress framework, and; (2) to develop and test the efficacy of evidence-based psychosocial and pharmacological interventions that promote arousal regulation and decreased inflammation. Our lab is comprised of ten doctoral candidates at the PGSP-Stanford Psy.D. Consortium, post-baccalaureate scholars, and Stanford undergraduates. Lab members routinely conduct sub-studies exploring important questions about roles for biological markers of inflammation, expressed emotion, personality factors, and neurocognitive functioning. The PI Lab has recently presented data at the Association for Behavioral and Cognitive Therapies (ABCT), Society for Personality Assessment (SPA), and Society for Affective Science Annual Meetings. We collaborate with Drs. Trisha Suppes and Michael Berk on a joint international project (R34 MH091284) with the University of Melbourne involving development and refinement of an internet-based intervention (MoodSwings) for adults with bipolar disorder (www.moodswings.net.au). The PI Lab also collaborates with Dr. Roger McIntyre at the University of Toronto on a joint international project, funded by the Stanley Medical Research Institute, investigating the efficacy of intravenous infliximab in the treatment of bipolar depression in adults.